Coherus Oncology, Inc. CHRS
0.87 USD +0.06 (+7.97%)
Nov 4, 2026, 9:45 AM EST
0.8117 Day range 0.8699
0.746 52-week range 2.62
- YTD
- -38.75%
- 1 year
- -43.88%
Analyst view
Consensus: buy
Buy
Price target (mean) 5.90 +578.3% upside
Now 0.8698
- Target (low)
- 1.50
- Target (mean)
- 5.90
- Target (high)
- 8.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
- Strong buy2
- Buy4
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 8
- 2 months ago 9
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.12926 | -0.23 – 0.06469 | -0.6209 | +79.2% | 43.88M | -52.1% | 5 |
| Next quarter | -0.0645 | -0.08 – -0.049 | -0.32 | +79.8% | 60.00M | -22.1% | 2 |
| Current year | -0.64333 | -0.71 – -0.30081 | -1.98 | +67.6% | 255.58M | -0.6% | 5 |
| Next year | 0.00822 | -0.14 – 0.21288 | -0.64333 | +101.3% | 279.18M | +9.2% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | Baird | Maintained | Outperform | Outperform |
| Dec 4, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 8, 2024 | Baird | Maintained | Outperform | Outperform |
| Nov 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 16, 2024 | UBS | Downgrade | Buy | Neutral |
| Aug 5, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 1, 2024 | Baird | Maintained | Outperform | Outperform |
| May 24, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 13, 2024 | Truist Securities | Maintained | Buy | Buy |
| May 10, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 20, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 23, 2024 | Baird | Maintained | Outperform | Outperform |
| Jan 23, 2024 | Truist Securities | Maintained | Buy | Buy |
| Dec 27, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 7, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 28, 2023 | Truist Securities | Reiterated | Buy | Buy |
| Nov 17, 2023 | Baird | Initiated | — | Outperform |
| Nov 8, 2023 | Maxim Group | Downgrade | Buy | Hold |
| Nov 7, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 23, 2023 | Barclays | Maintained | Overweight | Overweight |
| Sep 26, 2023 | Truist Securities | Reiterated | Buy | Buy |
| Sep 26, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 3, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 24, 2023 | Citigroup | Initiated | — | Buy |
| Jul 14, 2023 | Truist Securities | Maintained | Buy | Buy |
| Jun 28, 2023 | Truist Securities | Reiterated | Buy | Buy |
| Jun 20, 2023 | Truist Securities | Maintained | Buy | Buy |
| Jun 20, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |